GENOCEA BIOSCIENCES INC (GNCA) Stock Cash Flow
NASDAQ:GNCA - Nasdaq - US3724274010 - Common Stock
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -37.20M | -33.20M | -43.71M | -38.95M | -27.81M | |||
| Depreciation Amortization | 1.58M | 1.56M | 1.14M | 1.10M | 1.09M | |||
| Change In Working Capital | 2.39M | 2.27M | 3.17M | -1.32M | -4.94M | |||
| Interest Paid | 540.00K | 580.00K | 1.05M | 1.10M | 1.07M | |||
| Other non cash items | -14.96M | -16.00M | -2.24M | 1.44M | -9.57M | |||
| OPERATING CASH FLOW | -48.19M | -45.37M | -41.65M | -37.73M | -41.24M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.14M | -3.29M | -2.59M | -1.14M | -240.00K | |||
| Other Investing Activity | 30.00K | 80.00K | 30.00K | 50.00K | 110.00K | |||
| INVESTING CASH FLOW | -3.11M | -3.21M | -2.56M | -1.09M | -130.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.50M | -5.23M | -130.00K | -1.92M | 60.00K | |||
| Stock Issued/Repurchased | 7.90M | 11.57M | 83.98M | 54.69M | 2.99M | |||
| Other Financing Activity | N/A | -380.00K | N/A | 130.00K | 52.41M | |||
| FINANCING CASH FLOW | 5.40M | 5.96M | 83.85M | 52.90M | 55.46M | |||
| CHANGE IN CASH | -45.90M | -42.62M | 39.64M | 14.08M | 14.09M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -48.19M | -45.37M | -41.65M | -37.73M | -41.24M | |||
| Capital Expenditure | -3.14M | -3.29M | -2.59M | -1.14M | -240.00K | |||
| FREE CASH FLOW | -51.33M | -48.66M | -44.24M | -38.87M | -41.48M | |||
All data in USD